Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy

Journal of Urology

Volumn 171, Issue 2 I, 2004, Pages 570-574

  Slaton, Joel W ^a,b   Millikan, Randall ^a   Inoue, Keiji ^a   Karashima, Takashi ^a   Czerniak, Bogdan ^a   Shen, Yu ^a   Yang, Ying ^a   Benedict, William F ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Carcinoma; Cystectomy; Drug therapy; Neoplasm metastasis; Prognosis; Transitional cell

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BASIC FIBROBLAST GROWTH FACTOR GENE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORIMETRIC IN SITU HYBRIDIZATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; E CADHERIN GENE; FEMALE; GENE; GENE EXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERLEUKIN 8 GENE; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 9 GENE; METASTASIS; MULTIMODALITY CANCER THERAPY; ONCOGENE; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RNA HYBRIDIZATION; TRANSITIONAL CELL CARCINOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE;

EID: 0346499095     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000108845.91485.20     Document Type: Article

References (20)

1. Stein, J. P., Lieskovsky, G., Cote, R., Groshen, S., Feng, A. C. Boyd, S. et al: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol, 19: 666, 2001
2. Dalbagni, G., Genega, E., Hashibe, M., Zhang, Z.-F., Russo, P., Herr, H. et al: Cystectomy for bladder cancer: a contemporary series. J Urol, 165: 1111, 2001
3. Stöckle, M., Meyenburg, W., Wellek, S., Voges, G., Gertenbach, U., Thüroff, J. W. et al: Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol, 148: 302, 1992
4. Skinner, D. G., Daniels, J. R., Russell, C. A., Lieskovsky, G., Boyd, S. D., Nichols, P. et al: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol, 145: 459, 1991
5. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet, 354: 533, 1999.
6. Grossman, H. B., Natale, R. B., Tangen, C. M., Speights, V. O., Vogelzang, N. J., Trump, D. L., et al: Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med, 349: 859, 2003
7. Gschwend, J. E., Fair, W. R. and Vieweg, J.: Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies. Eur Urol, 38: 121, 2000
8. Millikan, R., Dinney, C., Swanson, D., Sweeney, P., Ro, J. Y., Smith, T. L. et al: Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol, 19: 4005, 2001
9. Inoue, K., Slaton, J. W., Karashima, T., Yoshikawa C., Shuin T., Sweeney, P. et al: The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res, 6: 4866, 2000
10. Slaton, J. W., Karashima, T., Perrotte, P., Inoue K., Kim, S. J., Izawa, J. et al: Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherine expression in human transitional cell carcinoma of the bladder. Clin Cancer Res, 7: 2840, 2001
11. Kitadai, Y., Ellis, L. M., Tucker, S. L., Greene G. F., Bucana, C. D., Cleary, K. R. et al: Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. Am J Pathol, 149: 1541, 1996
12. Thykjaer, T., Workman, C., Kruhoffer, M., Demtroder, K., Wolf, H., Andersen, L. D. et al: Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res, 61: 2492, 2001
13. Esrig, D., Spruck, C. H., 3rd, Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S. et al: p53. nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol, 143: 1389, 1993
14. Logothetis, C. J., Xu, H. J., Ro, J. Y., Hu, S. X., Sahin, A., Ordonez, N. et al: Altered expression of the retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst, 84: 1256, 1992
15. Cote, R. J., Dunn, M. D., Chatterjee, S. J., Stein, J. P., Shi, S. R., Tran, Q. C. et al: Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res, 58: 1090, 1998
16. Jahnson, S. and Karlsson, M. G.: Predictive value of p53 and pRb immunostaining in locally advanced bladder cancer treated with cystectomy. J Urol, 160: 1291, 1998
17. Crew, J. P., O'Brien, T., Bicknell, R., Fuggle, S., Cranston, D. and Harris, A.: Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol, 161: 799, 1999.
18. Crew, J. P., O'Brien, T., Bradburn, M., Fuggle, S., Bicknell, R., Cranston D. et al: Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res, 57: 5281, 1997
19. Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W. and Roy, F.: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107, 1991
20. Mialhe, A., Louis, J., Montlevier, S., Peoch, M., Pasquier, D., Bosson, J. L. et al: Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors? Invasion Metastasis; 17: 124, 1997